- Home
- UMAC vs INCR Comparison
UMAC vs INCR Comparison
Compare UMAC & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UMAC
- INCR
- Stock Information
- Founded
- UMAC 2019
- INCR 1994
- Country
- UMAC United States
- INCR Israel
- Employees
- UMAC N/A
- INCR N/A
- Industry
- UMAC
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- UMAC
- INCR Health Care
- Exchange
- UMAC Nasdaq
- INCR Nasdaq
- Market Cap
- UMAC 134.1M
- INCR 84.5M
- IPO Year
- UMAC 2024
- INCR N/A
- Fundamental
- Price
- UMAC $8.80
- INCR $1.56
- Analyst Decision
- UMAC Strong Buy
- INCR
- Analyst Count
- UMAC 2
- INCR 0
- Target Price
- UMAC $19.00
- INCR N/A
- AVG Volume (30 Days)
- UMAC 5.9M
- INCR 18.7K
- Earning Date
- UMAC 08-13-2025
- INCR 08-15-2025
- Dividend Yield
- UMAC N/A
- INCR N/A
- EPS Growth
- UMAC N/A
- INCR N/A
- EPS
- UMAC N/A
- INCR N/A
- Revenue
- UMAC $6,988,704.00
- INCR $65,575,323.00
- Revenue This Year
- UMAC $160.90
- INCR $69.54
- Revenue Next Year
- UMAC $135.75
- INCR $41.75
- P/E Ratio
- UMAC N/A
- INCR N/A
- Revenue Growth
- UMAC 1029.19
- INCR N/A
- 52 Week Low
- UMAC $1.13
- INCR $1.17
- 52 Week High
- UMAC $23.62
- INCR $2.62
- Technical
- Relative Strength Index (RSI)
- UMAC 57.58
- INCR 57.53
- Support Level
- UMAC $7.80
- INCR $1.43
- Resistance Level
- UMAC $8.91
- INCR $1.50
- Average True Range (ATR)
- UMAC 1.06
- INCR 0.06
- MACD
- UMAC -0.10
- INCR 0.00
- Stochastic Oscillator
- UMAC 36.53
- INCR 100.00
About UMAC Unusual Machines Inc. Common Stock
Unusual Machines Inc is engaged in serving the American drone industry by building and selling drone components.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.